Analyst Expectations for Belite Bio's Future
Portfolio Pulse from Benzinga Insights
In the last 3 months, 4 analysts have offered 12-month price targets for Belite Bio (NASDAQ:BLTE), with an average price target of $56.75, a decrease of 2.16% from the previous average of $58.00.
June 20, 2023 | 5:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Belite Bio has received 4 bullish analyst ratings in the last 3 months, with an average 12-month price target of $56.75, down 2.16% from the previous average.
The 4 bullish analyst ratings for Belite Bio in the last 3 months indicate a positive outlook for the stock. However, the decrease in the average 12-month price target from $58.00 to $56.75 suggests that analysts have slightly lowered their expectations for the stock's future performance. This could lead to a short-term increase in the stock price, but with a slightly lower potential upside.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100